Amelioration of insulin resistance in genetically obese rodents by M16209, a new antidiabetic agent

This publication has 14 references indexed in Scilit:

• Effects of M16209 on insulin secretion in isolated, perfused pancreases of normal and diabetic rats
  European Journal of Pharmacology, 1995
• Antihyperglycemic effects of M16209, a novel aldose reductase inhibitor, in normal and diabetic rats
  European Journal of Pharmacology, 1995
• Effects of novel aldose reductase inhibitors, M16209 and M16287, on streptozotocin-induced diabetic neuropathy in rats
  European Journal of Pharmacology, 1991
• Properties of Novel Aldose Reductase Inhibitors, M16209 and M16287, in Comparison with Known Inhibitors, ONO-2235 and Sorbinil.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1991
• Effects of Novel Hydantoin Derivatives with Aldose Reductase Inhibiting Activity on Galactose-Induced Cataract in Rats
  The Japanese Journal of Pharmacology, 1990
• Hyperinsulinemia is characterized by jointly disturbed plasma VLDL, LDL, and HDL levels. A population-based study.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
• In vivo hepatic and peripheral insulin sensitivity in rats with non-insulin-dependent diabetes induced by streptozocin. Assessment with the insulin-glucose clamp technique
  Diabetes, 1985
• The metabolic clearance of glucose: measurement and meaning
  Diabetologia, 1985
• Diabetic Hypertriglyceridemia: Evidence for Three Clinical Syndromes
  Diabetes, 1981
• Effect of Acute Elevation of Plasma Glycerol, Triglyceride and FFA Levels on Glucose Utilization and Plasma Insulin
  Diabetes, 1968